Armis Biopharma, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Previously recorded as CHD Bioscience, Inc. (to 2022)
9
Ending by 2030
Nov 2029
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 2, 2026The maintenance fee for Wound care products with peracid compositions (US 9,044,527) comes due Dec 2, 2026. Unpaid by Jun 2, 2027, it lapses early.
- 1 fee due Jun 12, 2027The maintenance fee for Antimicrobial, disinfecting, and wound healing compositions and methods for producing and using the same (US 11,839,213) comes due Jun 12, 2027. Unpaid by Dec 13, 2027, it lapses early.
- 1 fee due Oct 30, 2027The maintenance fee for Compositions and methods for remediating chemical warfare agent exposed skin (US 11,969,399) comes due Oct 30, 2027. Unpaid by May 1, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,012,681 | α-keto peracids and methods for producing and using the same In force · From the USPTO record | In force | From the USPTO record | |
| US 9,018,412 | α-keto alkylperacids and methods for producing and using the same In force · From the USPTO record | In force | From the USPTO record | |
| US 9,468,622 | α-keto peracids and methods for producing and using the same In force · From the USPTO record | In force | From the USPTO record | |
| US 9,844,219 | Alpha-keto peracids and methods for producing and using the same In force · From the USPTO record | In force | From the USPTO record | |
| US 11,284,621 | Compositions comprising peroxyacid and methods for producing and using the same In force · From the USPTO record | In force | From the USPTO record | |
| US 8,445,717 | α-Keto alkylperacids and methods for producing and using the same In force · From the USPTO record | In force | From the USPTO record | |
| US 11,006,629 | Antimicrobial, disinfecting, and wound healing compositions and methods for producing and using the same In force · From the USPTO record | In force | From the USPTO record | |
| US 11,839,213 | Antimicrobial, disinfecting, and wound healing compositions and methods for producing and using the same In force · From the USPTO record | In force | From the USPTO record | |
| US 8,426,634 | α-keto peracids and methods for producing and using the same In force · From the USPTO record | In force | From the USPTO record | |
| US 9,044,527 | Wound care products with peracid compositions In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 16: 1 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 5 no status recorded